Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insulin-like growth factors: the unrecognised oncogenes.

× No keyword cloud information.

20 in total

1. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients.

Authors: M Pollak; J Costantino; C Polychronakos; S A Blauer; H Guyda; C Redmond; B Fisher; R Margolese
Journal: J Natl Cancer Inst Date: 1990-11-07 Impact factor: 13.506

2. Prospective study of relative weight, height, and risk of breast cancer.

Authors: S J London; G A Colditz; M J Stampfer; W C Willett; B Rosner; F E Speizer
Journal: JAMA Date: 1989-11-24 Impact factor: 56.272

3. Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Authors: M Kaleko; W J Rutter; A D Miller
Journal: Mol Cell Biol Date: 1990-02 Impact factor: 4.272

4. Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway.

Authors: S Tretli
Journal: Int J Cancer Date: 1989-07-15 Impact factor: 7.396

Review 5. Bovine growth hormone: human food safety evaluation.

Authors: J C Juskevich; C G Guyer
Journal: Science Date: 1990-08-24 Impact factor: 47.728

6. Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin.

Authors: V G Garzo; J H Dorrington
Journal: Am J Obstet Gynecol Date: 1984-03-01 Impact factor: 8.661

7. Abdominal obesity and breast cancer risk.

Authors: D V Schapira; N B Kumar; G H Lyman; C E Cox
Journal: Ann Intern Med Date: 1990-02-01 Impact factor: 25.391

8. Colonic polyps in patients with acromegaly.

Authors: I Klein; G Parveen; J S Gavaler; D H Vanthiel
Journal: Ann Intern Med Date: 1982-07 Impact factor: 25.391

Review 9. Insulin-like growth factors and cancer.

Authors: V M Macaulay
Journal: Br J Cancer Date: 1992-03 Impact factor: 7.640

10. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II)

Authors: P Bates; R Fisher; A Ward; L Richardson; D J Hill; C F Graham
Journal: Br J Cancer Date: 1995-11 Impact factor: 7.640

20 in total

1. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.

Authors: E M Tan
Journal: J Clin Invest Date: 2001-11 Impact factor: 14.808

Review 2. Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Authors: E M Tan; F-D Shi
Journal: Clin Exp Immunol Date: 2003-11 Impact factor: 4.330

3. Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.

Authors: Ferenc G Rick; Andrew V Schally; Luca Szalontay; Norman L Block; Karoly Szepeshazi; Mehrdad Nadji; Marta Zarandi; Florian Hohla; Stefan Buchholz; Stephan Seitz
Journal: Proc Natl Acad Sci U S A Date: 2012-01-18 Impact factor: 11.205

4. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

Authors: J L Varga; A V Schally; V J Csernus; M Zarándi; G Halmos; K Groot; Z Rékási
Journal: Proc Natl Acad Sci U S A Date: 1999-01-19 Impact factor: 11.205

Review 5. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.

Authors: Jian-Ying Zhang; Eng M Tan
Journal: Expert Rev Mol Diagn Date: 2010-04 Impact factor: 5.225

6. Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.

Authors: H Kiaris; A V Schally
Journal: Proc Natl Acad Sci U S A Date: 1999-01-05 Impact factor: 11.205

Review 7. Autoantibodies to tumor-associated antigens: reporters from the immune system.

Authors: Eng M Tan; Jianying Zhang
Journal: Immunol Rev Date: 2008-04 Impact factor: 12.988

8. Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma.

Authors: Alecia Malin; Qi Dai; Herbert Yu; Xiao-Ou Shu; Fan Jin; Yu-Tang Gao; Wei Zheng
Journal: Cancer Date: 2004-02-15 Impact factor: 6.860

9. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.

Authors: Brendan C Luey; Felicity E B May
Journal: Mol Cancer Date: 2016-01-22 Impact factor: 27.401

10. Energy balance, insulin resistance biomarkers, and breast cancer risk.

Authors: Alecia Malin Fair; Qi Dai; Xiao-Ou Shu; Charles E Matthews; Herbert Yu; Fan Jin; Yu-Tang Gao; Wei Zheng
Journal: Cancer Detect Prev Date: 2007-07-23